Fine Paul E M
Department of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine, Keppel St., London WC1E 7HT, UK.
Pathogens. 2024 Feb 20;13(3):183. doi: 10.3390/pathogens13030183.
The Global Polio Eradication Initiative made immense progress after its establishment in 1988 as a consequence of high coverage with various poliovirus vaccines in all populations of the world. Problems have arisen in recent years, however, related to security issues in some countries, to the circulation of vaccine-derived polioviruses, and to the recognition that individuals with certain immune deficiencies can remain infected and infectious for many months or years. As natural infection and different vaccines have different effects on the immune system, the patterns of humoral and mucosal immunity to polioviruses in the world today are complex but are crucial to the ultimate success of the eradication initiative. This paper describes the background of the current situation and current immunological patterns and discusses their implications for managing population immunity to polioviruses in the years ahead.
全球根除脊髓灰质炎行动于1988年成立后,由于在世界所有人群中广泛接种各种脊髓灰质炎病毒疫苗,取得了巨大进展。然而,近年来出现了一些问题,涉及一些国家的安全问题、疫苗衍生脊髓灰质炎病毒的传播,以及认识到某些免疫缺陷个体可能在数月或数年时间内持续感染并具有传染性。由于自然感染和不同疫苗对免疫系统有不同影响,当今世界对脊髓灰质炎病毒的体液免疫和黏膜免疫模式复杂,但对于根除行动的最终成功至关重要。本文描述了当前形势的背景和当前的免疫模式,并讨论了它们对未来几年管理人群对脊髓灰质炎病毒免疫力的影响。